Acarix AB (publ) (STO:ACARIX)

Market Cap	333.10M +16.2%
Revenue (ttm)	7.36M +18.7%
Net Income	-48.09M
EPS	-0.04
Shares Out	1.16B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	670,167
Average Volume	1,086,987
Open	0.2830
Previous Close	0.2860
Day's Range	0.2750 - 0.2945
52-Week Range	0.1914 - 0.4710
Beta	-0.15
RSI	52.49
Earnings Date	Apr 15, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 8
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX

Financial Performance

In 2025, Acarix AB's revenue was 7.36 million, an increase of 18.69% compared to the previous year's 6.20 million. Losses were -48.09 million, -27.34% less than in 2024.